321.20DKK+2.10%Mkt Cap: 3.19B $P/E: 8.21Today
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on …
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap3.19B $
Enterprise Value1.13B $
Revenue (TTM)676.39M $
Gross Profit1.34B $
Net Income (TTM)940.19M $
Revenue/Share9.608 USD
Last Price321.20 DKK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees578
CountryDK
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)8.21
P/E (Forward)58.47
PEG—
EV/EBITDA3.34
EV/Revenue1.67
P/S4.61
P/B1.21
EPS (TTM)39.15
EPS (Forward)5.38
52W Range
233.5027% of range556.00
52W High556.00 DKK
52W Low233.50 DKK
Profitability
Gross Margin99.99%
Oper. Margin85.93%
EBITDA Margin50.05%
Profit Margin70.05%
ROE43.52%
ROA40.47%
Growth
Revenue Growth-50.60%
Earnings Growth-47.60%
Cash Flow & Leverage
Operating CF951.39M $
CapEx (TTM)10.06M $
FCF Margin-44.44%
FCF Yield-9.43%
Net Debt-2.05B $
Net Debt/EBITDA-6.04
Balance Sheet
Debt/Equity0.03
Current Ratio13.98
Quick Ratio13.76
Book Value/Sh259.59 DKK
Cash/Share208.49 DKK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 DKK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)441.93 DKK
Upside (mean)+37.6%
Target Range300.00 DKK – 745.00 DKK
DKK300.00+37.6% to meanDKK745.00
# Analysts14
Ownership
Shares Out.68.11M
Float55.43M
Insiders0.53%
Institutions43.23%
Technical
SMA 50300.93 (+6.7%)
SMA 200361.87 (-11.2%)
Beta0.60
S&P 52W Chg18.16%
Avg Vol (30d)324.18K
Avg Vol (10d)354.21K
Technical Indicators
RSI (14)51.7
MACD5.5900
MACD Signal6.7033
MACD Hist.-1.1133
BB Upper339.52 DKK
BB Middle314.59 DKK
BB Lower289.65 DKK
BB Width15.86%
ATR (14)12.97 DKK
Vol Ratio (20d)1.02x